SCHEMBL28359245

SCHEMBL28359245

O=C(O)c1nnc(-c2c(F)cccc2F)cc1Nc1ccc(N2CCOCC2)cn1

nearest known ligand 0.85

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 12/20 0.85
▸ JAK2 O60674 11/20 0.85
▸ JAK1 P23458 3/20 0.85
▸ JAK3 P52333 3/20 0.85
▸ DGAT1 O75907 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28362658 0.92 TYK2 (1.00) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL29552223 0.87 TYK2 (0.86) TYK2JAK2JAK1JAK3
SCHEMBL29551994 0.86 TYK2 (0.69) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL29552183 0.81 TYK2 (0.85) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL29551800 0.81 TYK2 (0.58) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL28362542 0.81 TYK2 (0.76) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL29552999 0.81 TYK2 (0.57) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL28362686 0.80 TYK2 (0.66) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL29922578 0.80 TYK2 (0.58) TYK2JAK2JAK1JAK3DGAT1
SCHEMBL28358907 0.79 TYK2 (0.77) TYK2JAK2JAK1JAK3DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback